Hyperkeratotic Skin Adverse Events Induced by Anticancer Treatments: A Comprehensive Review Maria VastarellaGabriella FabbrociniVincent Sibaud Review Article 24 January 2020 Pages: 395 - 408
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab David J. JacksonStephanie KornJames G. Zangrilli Review Article Open access 02 April 2020 Pages: 409 - 425
Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic Review Andrea M. RussellElaine H. MorratoMeredith Y. Smith Systematic Review 04 February 2020 Pages: 427 - 446
Developing Predictive Models to Determine Patients in End-of-Life Care in Administrative Datasets Joel N. SwerdelJenna M. RepsPatrick B. Ryan Original Research Article Open access 14 January 2020 Pages: 447 - 455
An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System Kathryn MarwitzS. Christopher JonesMonica A. Muñoz Original Research Article 24 January 2020 Pages: 457 - 465
Adverse Events in Twitter-Development of a Benchmark Reference Dataset: Results from IMI WEB-RADR Juergen DietrichLucie M. GattepailleAntoni Wisniewski Original Research Article Open access 29 January 2020 Pages: 467 - 478
Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations Ola CasterYasunori AokiBirgitta Grundmark Original Research Article Open access 01 February 2020 Pages: 479 - 487
Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study Sieta T. de VriesPetra DenigEugene P. van Puijenbroek Original Research Article Open access 11 February 2020 Pages: 489 - 495
Systemic Adverse Events Associated with Compounded Topical Pain Products Jenny KimKaren KonkelLynda McCulley Research Letter 04 April 2020 Pages: 497 - 501
Comment on ‘Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures’ Philip Schaffalitzky de MuckadellClaes Christian Strom Letter to the Editor Open access 06 April 2020 Pages: 503 - 505